Ebola vaccine yields first hopes of clinical efficacy

An interim analysis of a clinical trial of Merck & Co. and NewLink Genetics’ Ebola vaccine showed that the vaccine has so far provided 100% … Full Article http://j.gs/5sTq

Click here to read full article